Trial
NCT00278200
Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
National Cancer Institute (NCI)
Condition
Lymphoproliferative Disorder
Intervention
Inactivated EBV-infected vaccine
Why stopped
Loss of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-25